Stay updated on Pexa-Vec and Nivolumab Combo in HCC Clinical Trial
Sign up to get notified when there's something new on the Pexa-Vec and Nivolumab Combo in HCC Clinical Trial page.

Latest updates to the Pexa-Vec and Nivolumab Combo in HCC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRecruitment status updated to no longer recruit participants, indicating the study has been terminated. The page also gained new help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and a site revision tag (Revision: v3.6.0), with the Intervention/Treatment heading added as part of the update.SummaryDifference0.6%

- Check17 days agoChange DetectedThe page now displays Revision: v3.5.5, indicating an updated page version rather than a change to the trial’s information.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing the previous revision tag. This indicates a minor update to the page version.SummaryDifference0.1%

- Check60 days agoChange DetectedClinicalTrials.gov updated the displayed site revision from **v3.5.2** to **v3.5.3**.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision: v3.5.2 updated from v3.5.0.SummaryDifference0.1%

- Check96 days agoChange DetectedAdded a Hepatocellular carcinoma topic tag and a new link to the Genetic and Rare Diseases Information Center in the Resources section. Updated the site revision from v3.4.3 to v3.5.0.SummaryDifference0.2%

Stay in the know with updates to Pexa-Vec and Nivolumab Combo in HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pexa-Vec and Nivolumab Combo in HCC Clinical Trial page.